| |
| |
|
| Insider
Information: |
Notman Donald |
| Relationship: |
Chief Financial Officer |
| City: |
Bedford |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
195,356 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
195,356 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Ocular Therapeutix, Inc |
OCUL |
Chief Financial Officer |
2024-02-05 |
195,356 |
2017-12-07 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
9 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| OCUL |
Ocular Therapeutix, Inc |
Chief Financial Officer |
• – – |
2024-02-05 |
4 |
S |
$4.86 |
$30,190 |
D/D |
(6,212) |
195,356 |
0 |
- |
|
| OCUL |
Ocular Therapeutix, Inc |
Chief Financial Officer |
• – – |
2024-02-03 |
4 |
A |
$0.00 |
$0 |
D/D |
61,636 |
201,568 |
0 |
- |
|
| OCUL |
Ocular Therapeutix, Inc |
Chief Financial Officer |
• – – |
2024-01-31 |
4 |
S |
$4.95 |
$31,843 |
D/D |
(6,433) |
139,932 |
0 |
- |
|
| OCUL |
Ocular Therapeutix, Inc |
Chief Financial Officer |
• – – |
2023-02-06 |
4 |
AS |
$4.24 |
$27,458 |
D/D |
(6,476) |
139,387 |
0 |
- |
|
| OCUL |
Ocular Therapeutix, Inc |
Chief Financial Officer |
• – – |
2023-01-30 |
4 |
A |
$0.00 |
$0 |
D/D |
55,556 |
145,863 |
0 |
- |
|
| OCUL |
Ocular Therapeutix, Inc |
Chief Financial Officer |
• – – |
2022-02-03 |
4 |
A |
$0.00 |
$0 |
D/D |
55,556 |
81,632 |
0 |
- |
|
| OCUL |
Ocular Therapeutix, Inc |
Chief Financial Officer |
• – – |
2019-06-14 |
4 |
B |
$4.33 |
$10,825 |
D/D |
2,500 |
24,049 |
2.74 |
- |
|
| OCUL |
Ocular Therapeutix, Inc |
Chief Financial Officer |
• – – |
2018-08-14 |
4 |
B |
$6.29 |
$78,625 |
D/D |
12,500 |
17,300 |
2.74 |
- |
|
| OCUL |
Ocular Therapeutix, Inc |
Chief Financial Officer |
• – – |
2017-12-07 |
4 |
B |
$4.00 |
$19,200 |
D/D |
4,800 |
4,800 |
2.74 |
- |
|
9 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
